신일제약(주) · KOSDAQ: 012790 · Pharmaceuticals and medicinal chemicals
No rule-based items found in the latest annual report or the last 12 months of filings. This is a limited automated check, not a clean bill of health.
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩89.1B | ₩89.4B | ₩80.6B |
| Operating income | ₩14.0B | ₩15.2B | ₩7.4B |
| Net income | ₩13.6B | ₩14.3B | ₩7.5B |
| Total assets | ₩152.5B | ₩165.9B | ₩169.5B |
| Total liabilities | ₩17.6B | ₩19.4B | ₩17.1B |
| Total equity | ₩134.9B | ₩146.5B | ₩152.3B |
| Share capital | ₩6.0B | ₩6.0B | ₩6.0B |
Separate statements · FY2025 operating margin 9.2% · liabilities to equity 11% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 49 (current) | 인덕회계법인 | Unqualified |
| Term 48 (prior) | 인덕회계법인 | Unqualified |
| Term 47 (two years prior) | 인덕회계법인 | Unqualified |
No change history reported in the latest annual report.
| Date | Filing | Original |
|---|---|---|
| 2026-08-14 | Half-year report (2026.06) | DART |
| 2026-06-04 | Officer / major shareholder ownership report | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-03-26 | Amended: Annual general meeting results | DART |
| 2026-03-26 | Annual general meeting results | DART |
| 2026-03-18 | Attachment added: Annual report (2025.12) | DART |
| 2026-03-17 | Audit report submitted | DART |
| 2026-03-10 | Notice of shareholders meeting | DART |
| 2026-03-10 | Resolution to convene shareholders meeting | DART |
| 2026-03-04 | Cash / in-kind dividend decision | DART |
| 2026-03-04 | Revenue or profit structure changed materially | DART |
| 2025-12-16 | Record date for cash / in-kind dividend | DART |
| 2025-12-16 | Record date / shareholder register closure set | DART |
| 2025-11-13 | Quarterly report (2025.09) | DART |
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.